Last reviewed · How we verify
Pantoprazole 40mg
Pantoprazole 40mg, marketed by Universitaire Ziekenhuizen KU Leuven, is a well-established proton pump inhibitor in the gastrointestinal therapeutic area. The key composition patent is set to expire in 2028, providing a significant period of market exclusivity. The primary risk is the potential increase in generic competition following the patent expiry.
At a glance
| Generic name | Pantoprazole 40mg |
|---|---|
| Also known as | Pantomed, Protonix, Apo-Pantoprazole, Pantoprazole, Pantorc |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock Patients (PHASE2, PHASE3)
- Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection (PHASE2)
- Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection (PHASE3)
- Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy (NA)
- Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery (PHASE2)
- Neuro-immune Interactions and PPI (PHASE4)
- Phototoxicity of Frequently Prescribed Medicines (NA)
- Non-Opioid Prescriptions After Arthroscopic Surgery in Canada (NO PAin) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pantoprazole 40mg CI brief — competitive landscape report
- Pantoprazole 40mg updates RSS · CI watch RSS
- Universitaire Ziekenhuizen KU Leuven portfolio CI